U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480629) titled 'The 10-Year Extended Follow-up of the DACAB Trial' on March 13.
Brief Summary: The goal of this observational study is to learn about the very long-term effects of different antiplatelet strategies in patients who underwent coronary artery bypass grafting (CABG) and participated in the original DACAB trial. The main questions it aims to answer are:
Does one year of treatment with ticagrelor plus aspirin (dual antiplatelet therapy) after CABG reduce the risk of major adverse cardiovascular events (MACE) over 10 years compared with aspirin alone or ticagrelor alone?
What are the long-term safety outcomes, including major bleeding e...